Feature | Cardiovascular Ultrasound | July 11, 2016 | Dave Fornell

Top Trends in Cardiovascular Ultrasound

Insights into cardiac ultrasound at the American Society of Echocardiography (ASE) 2016 Conference

Csound, GE ultrasound, cSound, Mitral valve, cardiac ultrasound, cardiac echo, echocardiography, echo advances, ASE.16, ASE 2016, advances in cardiovascular ultrasound

An example of improved cardiac ultrasound image processing using the GE cSound technology, which can create CT-like quality 3-D renderings of the anatomy.

There were several overall key trends evident at the 2016 meeting of the American Society of Echocardiography in June. These included echo playing a key role in structural heart evaluation and for procedural guidance, ways to reduce operator variability and increase reproducibility of cardiac exams, new emphasis on use of contrast echo and strain imaging, and a proliferation of hand-held ultrasound systems for point-of-care cardiovascular assessments.

 

Watch a video interview on echo trends with the authors of this article at ASE 2016.

car

Preoperative Planning for Structural Heart Disease

The evolution of transcatheter procedures, including transcatheter aortic valve replacement (TAVR), transcatheter mitral valve repair (TMVR) and transcatheter tricuspid valve repair (TTVR) used to repair structural heart disease, has led to growth in the preoperative planning market. As a result, this has influenced how cardiac ultrasound vendors market their products.

Many vendors offer advanced valve quantification applications, as well as preoperative planning software, for their premium-level systems. We are also beginning to see select vendors develop relationships with various technologically innovative companies, such as 3-D printing company Materialise, which prints models from computed tomography (CT), magnetic resonance imaging (MRI) and ultrasound images. These models are then used for preoperative planning. GE featured its collaboration with an advanced medical visualization software company, EchoPixel, which uses virtual reality software and glasses to display anatomy as 3-D interactive images. This technology was introduced as an experimental means of transcatheter valve replacement planning.

 

Read about how Echopixel’s technology may evolve into a replacement technology for angiography for transcatheter structural heart interventions.

 

Watch video “Transcatheter Structural Heart Procedure Navigation Technology Advances,” interview with Dr. Steven Little at ASE 2016.

 

Watch video “What is Required for Interventional Echo - Discussion With Dr. Rebecca Hahn”

 

Variability of the Ultrasound Exam

Establishing ways to increase reproducibility and reduce variability in cardiac measurements is an ongoing focus for clinicians and vendors. During the conference, speakers discussed the updated guidelines released in January of 2015 that provided updated normal ranges for chamber quantification and standardized measurement parameters in greater detail. Presenters stressed the need for clinicians to follow the various quantification criteria to decrease report variability. Patients should be able to see different physicians, sonographers and be imaged on different equipment without significant variability in their cardiac measurements.

In the exhibit hall, vendors highlighted the various advanced quantification applications that are aimed at increasing reproducibility in the cardiac exam through their premium-level systems. Many vendors offer on-cart advanced imaging technology and intuitive quantification software that can automatically compute ejection fraction and simplify myocardial strain analysis. By using the advanced software applications available and following a standardized measurement protocol, it is fair to presume these factors can reduce variability and increase the reproducibility of the ultrasound exam.

 

Watch the video “Echo Software Advances — New Cardiovascular Ultrasound Technologies at ASE 2015,” which covers many of the recent trends seen again on the show floor at ASE 2016.

 

 

Contrast Use With Echocardiography

Contrast use with echocardiography has been available for many years, but many programs do not use it on a daily basis. Currently, there are three contrast agents available on the market, and many echo programs have developed protocols for their use. All the major vendors have included software and workflow efficiencies for their equipment to assist customers with using contrast imaging, so the technology is available for users to incorporate this application. Contrast use can be especially helpful for the significant number of patients that are difficult to image. It has been suggested that contrast use increases the sensitivity for ischemia evaluation and is designated as appropriate use criteria by professional organizations. Some facilities have a low threshold for use with stress echo due to the enhanced imaging ability. However, many do not.

Although the use of contrast is practiced and encouraged by many professionals, acceptance and routine use is low for many programs. This is due to cost, logistics and staffing concerns though there are efforts underway on local and national levels to set standards and protocols to enhance the sonographer’s ability to use contrast. This includes training that would allow sonographers to start IVs on their own and remove the need for additional nursing staff. It also includes having standard orders in place that allow the sonographer to proceed with contrast imaging when standards are met.

Sonographers in many cases are already busy, and adding tasks and procedures to an already full schedule may face some opposition. There also are technological features being developed and used by vendors with the potential to minimize the need for contrast, providing alternate imaging technology to achieve the image to improve diagnostic ability.

 

Strain Imaging

The use of strain imaging in echocardiography has been around for many years; its use has grown as the technology has improved. Strain imaging is a powerful tool that can provide objective parameters to the otherwise subjective determination of global and regional wall motion.

Sessions at this year’s ASE regarding strain imaging attested to the current popularity as the attendance was heavy. When the audience was polled on strain imaging use, most of the audience members indicated they recently used this method. If this same poll had been taken just a few years ago, the results would have been very different.

Daily use of this tool is a part of many programs for diagnostic information for many disease states, including coronary heart disease, valvular heart disease, heart failure and cardiotoxicity tracking. In the recent past, there was a lack of agreement among vendors regarding strain imaging, but this has improved since. Now all major vendors offer this technology, which adds to the broad acceptance by users. However, in the sessions, there was mention of limitations, including poor image quality and the use of high frame rates, which lowers the- image quality. Some planned future developments are the addition of right ventricular (RV) strain, 3-D strain applications and even the ability to derive strain imaging down to the cardiac fiber level.

 

Watch a video on how cardiac strain is being applied to measure cardiac toxicity from cancer therapies.

 

Hand-held Ultrasound (HHU)

There continues to be controversy surrounding the use of small hand-held or pocket-sized ultrasound systems. Opponents of HHU systems are concerned its supporters are trying to replace the stethoscope, which is traditionally used during a physical exam. Proponents of the hand-held systems stressed the importance of using HHU in conjunction with the stethoscope and physical exam.

In the exhibit hall of the American Society of Echocardiography (ASE), SonoSite displayed the iViz with various transducer options. Philips displayed the Lumify and showcased the various applications available on the system.

Aside from the cost difference between a hand-held system, which can range from $7,000-$10,000, a $199 subscription in the case of the Lumify and a stethoscope, which can range from $150-250, there are many pros and cons to be considered when adopting this technology.

HHU can offer rapid assessment in emergent and critical care situations for shock, chest wall trauma and various other emergent issues. Supporters state that early diagnosis equates to quicker treatment and subsequently a decrease in mortality rates. By using a noninvasive ultrasound device instead of chest X-rays, it is possible to limit the patient’s exposure to radiation, as well as decrease the overall cost associated with assessing the patient in the emergency department.

The limited amount of user training was mentioned as a concern for those opposed to using HHU systems. Another concern was the lack of direct reimbursement for the use of HHU. These systems lack continuous wave Doppler capabilities, and not all systems allow for storage of images. Therefore, they do not meet the billing criteria for a limited echocardiogram study.

Proponents referenced various studies that have been conducted involving the use of HHU and noted these systems reduced time to diagnosis, reduced costs involved and provided reliable assessments. These results add to an ever-growing body of evidence that HHU systems are a clinical tool that can improve the quality of healthcare delivered when combined with a physical exam.

 

For more on advances in hand-held or pocket ultrasound technology, watch the video “Trends in Medical Imaging at RSNA 2015” which includes a segment with examples of the same technology shown at ASE 2016.

 

For more information of advances in cardiac ultrasound from the American College of Cardiology (ACC) 2016 meeting, watch the video” Trends in Cardiac Ultrasound at ACC.16.”

 

Cardiac Ultrasound Systems Comparison Charts

ITN has created an apples-to-apples comparison chart of technical specifications of both echocardiography and point of care ultrasound systems used for cardiac evaluation. The chart requires a login, which is free and only takes a minute to sign up. It can be accessed at www.itnonline.com/content/cardiovascular-ultrasound.

 

Editor’s note: Jon Brubaker, MBA, RCVT and Sabrina Newell MS, RCS, are clinical analysts from the evidence-based research and consulting company MD Buyline. It provides hospitals and healthcare systems information to help make sound financial decisions for purchased services, capital equipment and technology and consumables.

Related Content

A new study by Rashi Mehta--a researcher with the WVU School of Medicine and Rockefeller Neuroscience Institute--finds that focused ultrasound may induce an immunological healing effect in the brains of Alzheimer's patients.

A new study by Rashi Mehta--a researcher with the WVU School of Medicine and Rockefeller Neuroscience Institute--finds that focused ultrasound may induce an immunological healing effect in the brains of Alzheimer's patients. Image courtesy of Caylie Silveria/West Virginia University

News | Focused Ultrasound Therapy | March 02, 2021
March 3, 2021 — West Virginia University scientists used...
An example of cardiac ultrasound longitudinal strain measurements on the Epsilon EchoInsight software. This can be used to assess cardiotoxicity from chemotherapy agents. 

An example of cardiac ultrasound longitudinal strain measurements on the Epsilon EchoInsight software. This can be used to assess cardiotoxicity from chemotherapy agents. 

News | Cardio-oncology | February 25, 2021
February 25, 2020 — Results of a multi-centre, international, clinical trial co-led by Peter Munk Cardiac Centre (PMC
icobrain cva allows the quantitative assessment of tissue perfusion by reporting the volume of core and perfusion lesion by quantifying Tmax abnormality and CBF abnormality together with the mismatch volume and ratio
News | Artificial Intelligence | February 23, 2021
February 23, 2021 — icometrix, world leader in imaging...
GE Healthcare introduced its artificial intelligence (AI) automation features on its Voluson Swift ultrasound platform at the 2020 Radiological Society of North America (RSNA) virtual meeting. Features of this system include semi-automated contouring, auto identification of fetal anatomy and positioning on imaging. AI is seeing increasing integration in ultrasound systems from numerous vendors.

GE Healthcare introduced its artificial intelligence (AI) automation features on its Voluson Swift ultrasound platform at the 2020 Radiological Society of North America (RSNA) virtual meeting. Features of this system include semi-automated contouring, auto identification of fetal anatomy and positioning on imaging. AI is seeing increasing integration in ultrasound systems from numerous vendors.

Feature | Ultrasound Imaging | February 18, 2021 | By Dave Fornell, Editor
Recent advances in ultrasound image sy...
Insightec plans to expand in Latin America through a partnership with Strattner
News | Focused Ultrasound Therapy | February 16, 2021
February 16, 2021 — Insightec, a global healthcare company focused on creating the next generation of patient care, a
Brazilian researchers found that the higher the lung ultrasound score the greater the risk of ICU admission, intubation and death. Image courtesy of Julio Alencar

Brazilian researchers found that the higher the lung ultrasound score the greater the risk of ICU admission, intubation and death. Image courtesy of Julio Alencar

News | Coronavirus (COVID-19) | February 11, 2021
February 11, 2021 — ...

Images in 69-year-old man with biopsy-confirmed Gleason score 7 (3+4) prostate cancer. (a) Pretreatment axial T2-weighted fast spin-echo MRI scan (repetition time msec/echo time msec, 3820/97) shows tumor in midline anterior transition zone (arrow). (b) Intraoperative MRI scan shows contoured rectal wall (red line), prostate margin (blue outline), and region of interest (orange outline). Because the urethra was included in planned treatment volume, a suprapubic catheter was placed for continuous bladder drainage during treatment. (c) Intraoperative MRI scan shows focused ultrasound beam path (blue) overlaid on treatment plan. Rectangles illustrate each sonication spot. (d) Thermal map image obtained during treatment with heat deposition color coded in red overlaid on sonication spot. (e) Axial gadopentetate dimeglumine-enhanced MRI scan (230/2.97) obtained immediately after treatment shows devascularized ablated volume (arrows). (f) Corresponding T2-weighted fast spin-echo MRI scan (3820/97) at 5 months after ablation shows complete involution of transition zone. All seven cores from treatment area margins were negative for cancer at biopsy. Image courtesy of the Radiological Society of North America

News | Prostate Cancer | February 05, 2021
February 5, 2021 — A technique that delivers...